Assessment of Metabolic-GI & Liver Disorders
Assessing gastrointestinal and liver disorders requires both subjective data (patient history, with pain being the most common complaint) and objective data (physical examination, diagnostic tests) to form a complete clinical picture.
Invasive assessment techniques are crucial for diagnosis and include several key procedures. Blood glucose monitoring (HbA1C) tracks patterns in diabetes patients, with newer options like Continuous Glucose Monitoring (CGM) providing real-time readings through subcutaneous sensors. The Minimed 770G system even includes a built-in insulin pump for automated delivery.
Esophago-Gastroduodenoscopy (EGD) allows direct visualization of the upper GI tract using a lighted endoscope. Similarly, Endoscopic Retrograde Cholangio-Pancreatography (ERCP) combines endoscopy with X-rays to examine the bile ducts, pancreatic ducts, and gallbladder. ERCP has evolved from primarily diagnostic to therapeutic, enabling procedures like stone removal and biliary stenting.
💡 All endoscopic procedures require patients to remain NPO (nothing by mouth) for approximately 8 hours before the procedure, and patients typically receive sedation and medications to reduce secretions and relax smooth muscles.
Percutaneous Transhepatic Cholangiography (PTC) visualizes the biliary tract by injecting contrast medium directly into a bile duct in the liver. This technique helps distinguish between different causes of jaundice and identify obstructions. While largely replaced by less invasive imaging methods, PTC is still valuable for therapeutic procedures like biliary drainage and stent placement.
Liver biopsy, which removes a small tissue sample via needle aspiration, remains the definitive diagnostic test for many liver conditions. Nursing care focuses on monitoring for bleeding, which may present as severe pain, and positioning patients on their right side after the procedure to apply natural compression.









